Aoyama Renacell Clinic Launches Stem Cell Injection into Penile Cavernous Spongiosa Aoyama Renacell Clinic launches ED regeneration therapy by injecting stem cells into the corpus cavernosum penis

Aoyama Renacell Clinic (Aoyama NA Building 5F, 2-7-28 Kita-Aoyama, Minato-ku, Tokyo), a general incorporated association, will now begin full-scale "ED regenerative therapy" for refractory ED patients, injecting autologous fat-derived stem cells directly into the penile corpus cavernosum for the first time in Japan.

The clinic has received official approval from the Ministry of Health, Labour and Welfare for a total of eight regenerative medicine plans using stem cells, mainly for lifestyle-related diseases of middle-aged and older adults such as type 2 diabetes and atherosclerosis, and has a track record of approximately 200 stem cell treatments in FY2023.

The ninth approved "treatment for ED (erectile dysfunction) using adipose-derived mesenchymal stem cells" is a treatment in which adipose-derived stem cells extracted from the patient's own body are cultured, and 50 million cells are injected into the penile cavernous body with a very fine needle at a time, which is almost painless and has no risk of immune rejection since the patient's own cells are used. It is a highly safe treatment.

Although there are currently no clinics in Japan that provide full-scale ED treatment by injecting stem cells into the corpus cavernosum, clinical research is being actively conducted overseas, and many cases of remarkable improvement have been reported in patients with severe diabetes, patients after prostatectomy, and patients with intractable diseases such as Peyronie's disease, which are considered to be extremely difficult to improve. Aoyama Renacelle Clinic is a leading clinic for diabetes patients with diabetes mellitus.

Aoyama RENACEL Clinic has the best clinical track record in diabetes regenerative medicine in Japan, and in the process of focusing on stem cell therapy for diabetes and other lifestyle-related diseases of middle-aged and older adults, we were confronted with the fact that the majority of these patients also suffer from ED. In addition to intravenous stem cell infusion therapy for underlying diseases such as diabetes, we injected exosomes of our independently produced stem cell culture supernatant into the penile corpus callosum, and many patients showed remarkable improvement.

By simultaneously improving underlying diseases such as diabetes, etc., as needed, our clinic aims to cure ED by the power of the patient's own cells, unlike existing transient remedies such as erectile dysfunction drugs. In addition to patients with lifestyle-related diseases such as diabetes and patients after prostatectomy, patients with cardiac diseases such as angina pectoris and myocardial infarction who have difficulty taking high-risk drugs are also targeted.

For more information about our ED regenerative treatment, please visit: https://rena-cell.com/erectile_dysfunction

Company Profile

Company name: Terumikai General Incorporated Association

Representative Director: Taro Tsuchiya

Location: Aoyama NA Building 5F, 2-7-28 Kita-Aoyama, Minato-ku, Tokyo

Establishment : May 21, 2020

Business description: Operation of regenerative medicine clinics

URL ： https://rena-cell.com